Embryonic Stem Cell-Derived Glial Precursors as a Vehicle for Sulfamidase Production in the MPS-IIIA Mouse Brain
Pluripotent stem cells, including human embryonic stem cells and induced pluripotent stem cells, have generated much excitement about their prospects for use in cell transplantation therapies. This is largely attributable to their virtually unlimited growth potential, their ability to be precisely g...
Main Authors: | Aaron J. Robinson, Guoying Zhao, Joy Rathjen, Peter D. Rathjen, Rhonda G. Hutchinson, Helen J. Eyre, Kim M. Hemsley, John J. Hopwood |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-08-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368910X498944 |
Similar Items
-
Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
by: Nicolina Cristina Sorrentino, et al.
Published: (2019-12-01) -
Formation of Neural Precursor Cell Populations by Differentiation of Embryonic Stem Cells In Vitro
by: Joy Rathjen, et al.
Published: (2002-01-01) -
Enzyme replacement reduces neuropathology in MPS IIIA dogs
by: Allison C. Crawley, et al.
Published: (2011-08-01) -
Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice
by: Susanne Gustavsson, et al.
Published: (2019-12-01) -
Retinal Degeneration in MPS-IIIA Mouse Model
by: Daniela Intartaglia, et al.
Published: (2020-03-01)